← Leaderboards
Adam Wax
Massachusetts Institute Of Technology
$11,203,116
Attributed
$12,544,827
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,544,827 · 13
By mechanism
R01$8,302,554 · 4
R21$2,009,558 · 6
R18$1,401,940 · 1
R33$713,951 · 1
F32$116,824 · 1
Top collaborators
- Nicholas J Shaheen5 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Lev T. Perelman$24,479,528
- James G Fujimoto$16,514,633
- Chung-Chieh Yu$364,878
- Michael Stephen Feld$9,411,906
- Parag Kumar Mallick$7,338,792
Others in their field
Top investigators on “Measurement”
- Lawrence Corey · Fred Hutchinson Cancer Center$517,278,507
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$468,973,477
- David R. Weir · University Of Michigan At Ann Arbor$403,695,976
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$297,689,086
- Christopher McKay · Battelle Memorial Institute$290,340,771
- David H Reitze · University Of Florida$256,180,831
Research focus
MeasurementImageBaseMorphologyInterferometryDiagnosticResolutionTechnologyIn VivoTissuesScanningClinical ResearchNuclearAlzheimer&AposEpitheliumDetectionEvaluationLight ScatteringEpithelialOpticsInstrumentDiagnosisBarrett EsophagusCharacteristics
Grant awards (35)
Retinal Light Scattering Measurements as a Clinical Biomarker of Alzheimer's Disease$481,765
R01 · FY2025 · AG · contact PI
Retinal Light Scattering Measurements as a Clinical Biomarker of Alzheimer's Disease$491,598
R01 · FY2024 · AG · contact PI
Point of care diagnostic for sickle cell disease$179,818
R18 · FY2024 · EB · contact PI
Point of care diagnostic for sickle cell disease$1,222,122
R18 · FY2023 · EB · contact PI
Retinal Light Scattering Measurements as a Clinical Biomarker of Alzheimer's Disease$471,444
R01 · FY2023 · AG · contact PI
Retinal Light Scattering Measurements as a Clinical Biomarker of Alzheimer's Disease$493,158
R01 · FY2022 · AG · contact PI
Advanced a/LCI systems for improved clinical utility$553,002
R01 · FY2021 · CA · contact PI
Advanced a/LCI systems for improved clinical utility$564,879
R01 · FY2020 · CA · contact PI
Advanced a/LCI systems for improved clinical utility$575,728
R01 · FY2019 · CA · contact PI
High throughput cell screening for toxic metal exposure$194,177
R21 · FY2019 · ES · contact PI
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium$561,208
R01 · FY2018 · CA · contact PI
Advanced a/LCI systems for improved clinical utility$488,713
R01 · FY2018 · CA · contact PI
Coherent light scattering for early detection of Alzheimer's disease$231,988
R21 · FY2018 · AG · contact PI
High throughput cell screening for toxic metal exposure$209,312
R21 · FY2018 · ES · contact PI
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium$595,577
R01 · FY2017 · CA · contact PI
Advanced a/LCI systems for improved clinical utility$501,101
R01 · FY2017 · CA · contact PI
Coherent light scattering for early detection of Alzheimer's disease$192,501
R21 · FY2017 · AG · contact PI
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium$616,234
R01 · FY2016 · CA · contact PI
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium$628,544
R01 · FY2015 · CA · contact PI
Novel Coherence Imaging to Evaluate the Health of the Cervical Epithelium$645,906
R01 · FY2014 · CA · contact PI
Coherent light scattering for early detection of retinal disease$189,624
R21 · FY2014 · EY · contact PI
Coherent light scattering for early detection of retinal disease$227,150
R21 · FY2013 · EY · contact PI
Coherence Imaging for Assessing Colorectal Neoplasia$307,897
R01 · FY2010 · CA · contact PI
Coherence Imaging for Assessing Colorectal Neoplasia$325,800
R01 · FY2009 · CA · contact PI
In vivo detection of pre-cancerous lesions using a/LCL$242,344
R33 · FY2008 · CA · contact PI
Assessing Deployment of Microbicidal Gels With Label-Free Optical Measurement$191,295
R21 · FY2008 · AI · contact PI
In vivo detection of pre-cancerous lesions using a/LCL$253,703
R33 · FY2007 · CA · contact PI
Assessing Deployment of Microbicidal Gels With Label-Free Optical Measurement$227,840
R21 · FY2007 · AI · contact PI
Assessing nuclear morphology in thick tissues using fLCI$115,030
R21 · FY2007 · CA · contact PI
In vivo detection of pre-cancerous lesions using a/LCL$217,904
R33 · FY2006 · CA · contact PI
Assessing nuclear morphology in thick tissues using fLCI$139,610
R21 · FY2006 · CA · contact PI
In vivo detection of pre-cancerous lesions using a/LCL$91,031
R21 · FY2004 · CA
COHERENCE AND SPECTROSCOPY STUDIES FOR BIOMED IMAGING$44,212
F32 · FY2002 · RR
COHERENCE AND SPECTROSCOPY STUDIES FOR BIOMED IMAGING$40,196
F32 · FY2001 · RR
COHERENCE AND SPECTROSCOPY STUDIES FOR BIOMED IMAGING$32,416
F32 · FY2000 · RR